AQUATRECK ANIMAL HEALTH S.L. is a new aquaculture pharmaceutical company established in Galicia in Spain by CZVaccines S.A and MARINNOVAC Limited. AQUATRECK aims to support global aquaculture development providing autogenous, experimental and licensed vaccines and novel, innovative, reliable, accurate diagnostic services for the fish and shrimp farming industry. “The mission of AQUATRECK is to fast track innovative fish & shrimp disease prevention strategies by building effective open collaboration alliances of top talented teams to serve the global aquaculture industry’s sustainable future” Prof. Patrick Smith MARINNOVAC chairman “We have long experience as CMO GMP producers of fish vaccines for the last 25 years and we decided to focus to accelerate the sustainable global aquaculture growth by preventing the major fish and shrimp diseases so we launch today AQUATRECK a new dynamic open innovation aquatic health company” Andrés Fernández Álvarez-Santullano, CEO of CZ Vaccines S.A “AQUATRECK provides long experience in fish vaccine development, close collaboration and continuous interaction with fish and shrimp farmers to develop comprehensive health strategies, top level leading viral vaccine research and development facilities in Cambridge, UK, sub-unit fish vaccine research and development facilities in Dortmund, Germany, state of the art GMP Fish vaccine manufacturing facilities in Spain and a vibrant network of fish immunology and pathology scientists around the world. Dr. Panos Christofilogiannis AQUATRECK Director